Assessing the reliability and responsiveness of the SF-6Dv2 and comparing its validity to the EQ-5D-5L among colorectal cancer patients in China
SF-6Dv2 showed comparable reliability and responsiveness when used in patients with CRC, out-performing EQ-5D-5L in differentiating clinical known-groups and showing promise for cancer practice and research.
Authors
- Yiyin Cao (ORCID: https://orcid.org/0000-0001-8156-5537)
- Jiannan Sun (ORCID: https://orcid.org/0009-0003-1312-6307)
- Lemin Wu
- Weidong Huang (ORCID: https://orcid.org/0000-0003-2798-4735)
- Yujin Wang (ORCID: https://orcid.org/0000-0001-5982-4088)
- Lijun Xu (ORCID: https://orcid.org/0000-0001-9515-6128)
- Jiaxuan Shi
- Hongjuan Yu (ORCID: https://orcid.org/0000-0002-9382-4943)
- Jifeng Liu (ORCID: https://orcid.org/0000-0002-2874-2706)
Institutions
- Harbin Medical University (CN)
- Heilongjiang Provincial Hospital (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
- Heilongjiang Institute of Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.3389/fonc.2025.1657249
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.13
Funders
- National Natural Science Foundation of China